Page last updated: 2024-08-24

aromasil and Lymphopenia

aromasil has been researched along with Lymphopenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Guillaume, Z; Lillo-Lelouet, A; Marret, G; Medioni, J; Oudard, S; Simonaggio, A	1

Other Studies

1 other study(ies) available for aromasil and Lymphopenia

Article	Year
Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib. Clinical breast cancer, 2020, Volume: 20, Issue:2 Topics: Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Fatal Outcome; Female; Humans; Immunocompromised Host; Lymphocyte Count; Lymphopenia; Piperazines; Pneumocystis; Pneumonia, Pneumocystis; Pyridines; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination	2020

Article

Year

Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib.

Clinical breast cancer, 2020, Volume: 20, Issue:2

Topics: Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Fatal Outcome; Female; Humans; Immunocompromised Host; Lymphocyte Count; Lymphopenia; Piperazines; Pneumocystis; Pneumonia, Pneumocystis; Pyridines; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination

2020